Issue navigation
Volume 14, Issue 1, January 2020
Editorial
IM-UNITI at Three Years: Stellar Stelara® or Stardust? The Efficacy, Safety, and Immunogenicity of Ustekinumab Treatment of Crohn’s Disease
Journal of Crohn's and Colitis, Volume 14, Issue 1, January 2020, Pages 1–3, https://doi.org/10.1093/ecco-jcc/jjz133
ECCO Guideline/Consensus Paper
ECCO Guidelines on Therapeutics in Crohn's Disease: Medical Treatment
Journal of Crohn's and Colitis, Volume 14, Issue 1, January 2020, Pages 4–22, https://doi.org/10.1093/ecco-jcc/jjz180
Original Articles
IM-UNITI: Three-year Efficacy, Safety, and Immunogenicity of Ustekinumab Treatment of Crohn’s Disease
Journal of Crohn's and Colitis, Volume 14, Issue 1, January 2020, Pages 23–32, https://doi.org/10.1093/ecco-jcc/jjz110
Ustekinumab for Crohn’s Disease: Results of the ICC Registry, a Nationwide Prospective Observational Cohort Study
Journal of Crohn's and Colitis, Volume 14, Issue 1, January 2020, Pages 33–45, https://doi.org/10.1093/ecco-jcc/jjz119
Faecal Calprotectin Predicts Endoscopic and Histological Activity in Clinically Quiescent Ulcerative Colitis
Journal of Crohn's and Colitis, Volume 14, Issue 1, January 2020, Pages 46–52, https://doi.org/10.1093/ecco-jcc/jjz107
Direct and Indirect Costs of Inflammatory Bowel Disease: Ten Years of Follow-up in a Danish Population-based Inception Cohort
Journal of Crohn's and Colitis, Volume 14, Issue 1, January 2020, Pages 53–63, https://doi.org/10.1093/ecco-jcc/jjz096
Long-term Evaluation of Allogeneic Bone Marrow-derived Mesenchymal Stromal Cell Therapy for Crohn’s Disease Perianal Fistulas
Journal of Crohn's and Colitis, Volume 14, Issue 1, January 2020, Pages 64–70, https://doi.org/10.1093/ecco-jcc/jjz116
Complicated Disease and Response to Initial Therapy Predicts Early Surgery in Paediatric Crohn’s Disease: Results From the Porto Group GROWTH Study
Journal of Crohn's and Colitis, Volume 14, Issue 1, January 2020, Pages 71–78, https://doi.org/10.1093/ecco-jcc/jjz111
IL-12 and Mucosal CD14+ Monocyte-Like Cells Induce IL-8 in Colonic Memory CD4+ T Cells of Patients With Ulcerative Colitis but not Crohn’s Disease
Journal of Crohn's and Colitis, Volume 14, Issue 1, January 2020, Pages 79–95, https://doi.org/10.1093/ecco-jcc/jjz115
Deregulation of Long Intergenic Non-coding RNAs in CD4+ T Cells of Lamina Propria in Crohn’s Disease Through Transcriptome Profiling
Journal of Crohn's and Colitis, Volume 14, Issue 1, January 2020, Pages 96–109, https://doi.org/10.1093/ecco-jcc/jjz109
Faecal Micro-RNAs in Inflammatory Bowel Diseases
Journal of Crohn's and Colitis, Volume 14, Issue 1, January 2020, Pages 110–117, https://doi.org/10.1093/ecco-jcc/jjz120
Systemic Molecular Mediators of Inflammation Differentiate Between Crohn’s Disease and Ulcerative Colitis, Implicating Threshold Levels of IL-10 and Relative Ratios of Pro-inflammatory Cytokines in Therapy
Journal of Crohn's and Colitis, Volume 14, Issue 1, January 2020, Pages 118–129, https://doi.org/10.1093/ecco-jcc/jjz117
Oral Targeted Delivery by Nanoparticles Enhances Efficacy of an Hsp90 Inhibitor by Reducing Systemic Exposure in Murine Models of Colitis and Colitis-Associated Cancer
Journal of Crohn's and Colitis, Volume 14, Issue 1, January 2020, Pages 130–141, https://doi.org/10.1093/ecco-jcc/jjz113
Short Report
Remission of Inflammatory Bowel Disease in Glucose-6-Phosphatase 3 Deficiency by Allogeneic Haematopoietic Stem Cell Transplantation
Journal of Crohn's and Colitis, Volume 14, Issue 1, January 2020, Pages 142–147, https://doi.org/10.1093/ecco-jcc/jjz112
Letter to the Editor
Comment on: ‘Resolution of CMV Infection in the Bowel on Vedolizumab Therapy’
Journal of Crohn's and Colitis, Volume 14, Issue 1, January 2020, Pages 148–149, https://doi.org/10.1093/ecco-jcc/jjz108
